Profile data is unavailable for this security.
About the company
Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.
- Revenue in CAD (TTM)70.65m
- Net income in CAD-19.60m
- Incorporated2001
- Employees200.00
- LocationDelta 9 Cannabis IncOsborne VillagePO Box 68096WINNIPEG R3L 2V9CanadaCAN
- Phone+1 (204) 997-5328
- Fax+1 (204) 997-5328
- Websitehttps://www.delta9.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eve & Co Inc | 7.77m | -5.92m | 3.74m | -- | -- | -- | -- | 0.482 | -0.2055 | -0.2055 | 0.2698 | 0.733 | 0.1519 | 0.7493 | 8.73 | -- | -11.58 | -- | -24.24 | -- | -3.10 | -- | -76.22 | -- | 0.062 | -5.05 | 0.4892 | -- | 2.94 | -- | -71.97 | -- | -- | -- |
| Marvel Biosciences Corp | 0.00 | -2.51m | 4.18m | -- | -- | -- | -- | -- | -0.0632 | -0.0632 | 0.00 | -0.0617 | 0.00 | -- | -- | -- | -372.25 | -- | -- | -- | -- | -- | -- | -- | -- | -26.43 | -- | -- | -- | -- | 10.29 | -- | -- | -- |
| Appili Therapeutics Inc | 1.15m | -5.34m | 4.24m | 8.00 | -- | -- | -- | 3.69 | -0.044 | -0.044 | 0.0095 | -0.0811 | 0.5047 | -- | 2.12 | -- | -234.31 | -117.41 | -- | -173.66 | -- | -- | -464.23 | -3,037.15 | -- | -5.32 | -- | -- | -75.97 | -- | 63.20 | -- | -43.04 | -- |
| Delta 9 Cannabis Inc | 70.65m | -19.60m | 4.44m | 200.00 | -- | -- | -- | 0.0629 | -0.1022 | -0.1022 | 0.3695 | -0.0393 | 0.8962 | 3.21 | 33.79 | 353,264.40 | -23.37 | -13.74 | -73.68 | -23.39 | 26.06 | 26.99 | -26.08 | -17.98 | 0.0875 | -4.29 | 1.18 | -- | 12.39 | 56.50 | 35.61 | -- | -48.22 | -- |
| Innovotech Inc | 1.24m | -176.78k | 4.68m | 16.00 | -- | 5.64 | -- | 3.77 | -0.0045 | -0.0045 | 0.0319 | 0.0213 | 1.13 | 6.10 | 7.97 | -- | -16.10 | 2.90 | -19.15 | 3.56 | 69.63 | 71.56 | -14.25 | 2.19 | 2.24 | -- | 0.00 | -- | 5.05 | 7.42 | -15.43 | -- | 35.69 | -- |
| Therma Bright Inc | 25.80k | -2.88m | 4.74m | -- | -- | 2.58 | -- | 183.67 | -0.0115 | -0.0115 | 0.0001 | 0.0058 | 0.0076 | 0.0023 | 0.115 | -- | -84.40 | -220.66 | -165.23 | -444.57 | 98.45 | -- | -11,152.48 | -10,853.16 | 0.0447 | -184.52 | 0.0411 | -- | -82.86 | 11.13 | 35.93 | -- | 40.15 | -- |
| StageZero Life Sciences Ltd | -100.00bn | -100.00bn | 4.92m | 40.00 | -- | -- | -- | -- | -- | -- | -- | -0.1125 | -- | -- | -- | -- | -- | -135.76 | -- | -- | -- | -2.74 | -- | -246.92 | 0.0176 | -- | -- | -- | -25.12 | 55.93 | -52.53 | -- | -- | -- |
| Principal Technologies Inc | 581.16k | -1.52m | 4.93m | -- | -- | 6.07 | -- | 8.48 | -0.0657 | -0.0657 | 0.0257 | 0.0247 | 0.577 | -- | 3.71 | -- | -147.50 | -- | -286.94 | -- | 42.98 | -- | -255.65 | -- | -- | -59.80 | 0.0757 | -- | 25.43 | -- | 23.53 | -- | -- | -- |
